How to Buy Zenith Drugs Ltd Shares?
You can easily buy the stocks/shares of Zenith Drugs Ltd (ZENITHDRUG) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Zenith Drugs Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of ZENITHDRUG as on 15th May 2025 is ₹86.29What is the return on Zenith Drugs Ltd share?
The past returns of Zenith Drugs Ltd (ZENITHDRUG) share are- Past 1 week: N/A
- Past 1 month: N/A
- Past 3 months: 20.04
- Past 6 months: -21.22
- Past 1 year: 7.98
- Past 3 years: N/A
- Past 5 years: -35.05
What is the Dividend yield % on Zenith Drugs Ltd share?
The current dividend yield of Zenith Drugs Ltd (ZENITHDRUG) is N/AWhat is the Market Cap of Zenith Drugs Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Zenith Drugs Ltd (ZENITHDRUG) is ₹117.13Cr as of 15th May 2025What is the 52 Week High and Low of Zenith Drugs Ltd?
The 52-week high and low of Zenith Drugs Ltd (ZENITHDRUG) is ₹154.40 and ₹47.15.What is the PE and PB ratio of Zenith Drugs Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Zenith Drugs Ltd are 16.36 and 1.88 respectively.Which sector does Zenith Drugs Ltd belong to?
Zenith Drugs Ltd (ZENITHDRUG) belongs to the Health Care sector & Pharmaceuticals sub-sector.What are the peers or stocks similar to Zenith Drugs Ltd?
The peers or stocks similar to Zenith Drugs Ltd are: and many others.Can't decide whether or not to buy Zenith Drugs Ltd?
Worry no more! Login to Tickertape and check out Zenith Drugs Ltd (ZENITHDRUG) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Zenith Drugs Ltd?
The 52-week high and low of Zenith Drugs Ltd (ZENITHDRUG) is ₹154.40 and ₹47.15.1. Test Stocks FAQ for Zenith Drugs Ltd Shares?
You can easily buy the stocks/shares of Zenith Drugs Ltd (ZENITHDRUG) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Zenith Drugs Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of ZENITHDRUG as on 15th May 2025 is ₹86.29
Zenith Drugs Ltd
ZENITHDRUG Share Price
86.298.54% (+6.79)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
ZENITHDRUG Performance & Key Metrics
ZENITHDRUG Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 1.88 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.65 | 6.55 | 0.84% |
ZENITHDRUG Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ZENITHDRUG Company Profile
Zenith Drugs is an India-based pharmaceutical manufacturing and trading company.
SUNPHARMA
PE Ratio
36.18
36.18
1Y Return
9.57%
9.57%
Buy Reco %
89.19
89.19
CIPLA
PE Ratio
22.95
22.95
1Y Return
3.96%
3.96%
Buy Reco %
71.05
71.05
DRREDDY
PE Ratio
19.32
19.32
1Y Return
10.25%
10.25%
Buy Reco %
82.05
82.05
TORNTPHARM
PE Ratio
57.15
57.15
1Y Return
11.83%
11.83%
Buy Reco %
67.74
67.74
MANKIND
PE Ratio
48.88
48.88
1Y Return
6.55%
6.55%
Buy Reco %
—
—
ZENITHDRUG Sentiment Analysis
ZENITHDRUG Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
ZENITHDRUG Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
ZENITHDRUG Stock Growth Drivers
ZENITHDRUG Stock Growth Drivers
4Focus on Sustainable Growth
Company is prioritizing profitable growth over mere expansion, emphasizing a strategy that encourages ground-level teams
Stable Financial Metrics
The company has maintained a return on assets (ROA) of 1.9% post-merger, showcasing stability in
ZENITHDRUG Stock Challenges
ZENITHDRUG Stock Challenges
3Deposit Growth Shortfalls
The company has experienced deposit growth that has not met expectations, attributed to seasonal trends
Loan Growth Concerns
There is uncertainty regarding the company's loan deposit ratio (LDR) and its implications for loan
ZENITHDRUG Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
ZENITHDRUG Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
ZENITHDRUG
ZENITHDRUG
Income
Balance Sheet
Cash Flow
Annual Normal View
ZENITHDRUG Income Statement
ZENITHDRUG Income Statement
Annual Normal View
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 78.33 | 73.52 | 92.67 | 115.76 | 133.90 | 135.93 | — | |||||||
Raw Materials | 71.23 | 66.20 | 49.14 | 45.52 | 36.41 | 119.99 | — | |||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | |||||||||||
| Employee Cost | 2.84 | 4.09 | 5.34 | |||||||||||
| Selling & Administrative Expenses | 6.53 | 15.59 | 15.63 | |||||||||||
| Operating & Other expenses | 26.19 | 40.27 | 58.77 | |||||||||||
EBITDA | 7.10 | 7.32 | 7.97 | 10.29 | 17.75 | 15.94 | — | |||||||
| Depreciation/Amortization | 0.92 | 1.22 | 1.33 | 1.31 | 1.30 | 2.97 | — | |||||||
| PBIT | 6.18 | 6.10 | 6.64 | 8.98 | 16.45 | 12.97 | — | |||||||
| Interest & Other Items | 1.31 | 1.49 | 2.24 | 2.33 | 3.00 | 3.71 | — | |||||||
| PBT | 4.87 | 4.61 | 4.40 | 6.65 | 13.45 | 9.26 | — | |||||||
| Taxes & Other Items | 1.47 | 1.53 | 1.27 | 1.78 | 3.84 | 2.10 | — | |||||||
| Net Income | 3.40 | 3.08 | 3.13 | 4.87 | 9.61 | 7.16 | — | |||||||
| EPS | 85.00 | 76.66 | 78.25 | 121.75 | 10.95 | 4.18 | — | |||||||
| DPS | — | — | 0.00 | 0.00 | 0.50 | 0.00 | — | |||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | — |
ZENITHDRUG Company Updates
ZENITHDRUG Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
ZENITHDRUG Past Performance & Peer Comparison
ZENITHDRUG Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Zenith Drugs Ltd | 16.36 | 1.88 | — |
| Sun Pharmaceutical Industries Ltd | 36.18 | 5.89 | 0.97% |
| Cipla Ltd | 22.95 | 4.51 | 1.07% |
| Dr Reddy's Laboratories Ltd | 19.32 | 3.87 | 0.61% |
ZENITHDRUG Stock Price Comparison
Compare ZENITHDRUG with any stock or ETFCompare ZENITHDRUG with any stock or ETF
ZENITHDRUG
ZENITHDRUG Holdings
ZENITHDRUG Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
ZENITHDRUG Promoter Holdings Trend
ZENITHDRUG Promoter Holdings Trend
ZENITHDRUG Institutional Holdings Trend
ZENITHDRUG Institutional Holdings Trend
No institutional holdings trend are available
ZENITHDRUG Shareholding Pattern
ZENITHDRUG Shareholding Pattern
ZENITHDRUG Shareholding History
ZENITHDRUG Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ZENITHDRUG stock
smallcases containing ZENITHDRUG stock
Looks like this stock is not in any smallcase yet.
ZENITHDRUG Events
ZENITHDRUG Events
ZENITHDRUG Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
ZENITHDRUG Dividend Trend
No dividend trend available
ZENITHDRUG Upcoming Dividends
ZENITHDRUG Upcoming Dividends
No upcoming dividends are available
ZENITHDRUG Past Dividends
ZENITHDRUG Past Dividends
Cash Dividend
Ex DateEx DateSep 17, 2024
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Sep 17, 2024
ZENITHDRUG Stock News & Opinions
ZENITHDRUG Stock News & Opinions
Articles & Videos
Corporate
Zenith Drugs to hold board meeting
Zenith Drugs will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Zenith Drugs to hold board meeting
Zenith Drugs will hold a meeting of the Board of Directors of the Company on 12 April 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Zenith Drugs to table results
Zenith Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Zenith Drugs to convene AGM
Zenith Drugs announced that the 24th Annual General Meeting (AGM) of the company will be held on 25 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant